Delivery Order SPE2DB22D2214-SPE2DB24FS4UX

Award Date 5/9/24
Potential Completion Date 5/10/24
Potential Value $1.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $22,383.03 and has an ultimate completion date of July 1, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and is valued at $2,230.72. The contract is a Firm Fixed Price Delivery Order with a completion date of June 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,238.27 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a firm fixed price of $2,465.48. The award is a delivery order that is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA), a component of the Department of Defense. The $49,013.23 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 11, 2024 with a completion date of June 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,704.64 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on August 28, 2024, with a completion date of August 29, 2024. The contract is not designated as a set-aside and represents a task order under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which...
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $8,119.86, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of July 10, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S pharmaceutical products. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 5, 2024. The contract has a firm fixed price of $5,056.61 and a completion date of September 6, 2024. This appears to be a delivery order against an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and...
This federal contract award is a delivery order for OTEZLA 30 MG TABLET 60S valued at $9,172.52, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of October 18, 2024 and is a firm fixed-price arrangement. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 5, 2024. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $16,637.18 and a completion date of January 8, 2024. The contract was not designated with any set-aside requirements. Amerisourcebergen Drug...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS4UX
    Delivery Order

This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $1,328.56, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 10, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

Generated 8/8/24, 10:37 AM